Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma
NCT02341209
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
Low enrollment
Conditions
Cutaneous T-cell Lymphoma
Mycosis Fungoides
Sezary Syndrome
Interventions
DRUG:
Doxycycline monohydrate
Sponsor
Rochester General Hospital